Zhejiang Haisen Pharmaceutical Co. Ltd. A
Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, sale, and import and export of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, cardiovascular,… Read more
Market Cap & Net Worth: Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367)
Zhejiang Haisen Pharmaceutical Co. Ltd. A (SHE:001367) has a market capitalization of $480.69 Million (CN¥3.53 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #16537 globally and #4389 in its home market, demonstrating a 0.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Haisen Pharmaceutical Co. Ltd. A's stock price CN¥23.15 by its total outstanding shares 152351200 (152.35 Million).
Zhejiang Haisen Pharmaceutical Co. Ltd. A Market Cap History: 2023 to 2026
Zhejiang Haisen Pharmaceutical Co. Ltd. A's market capitalization history from 2023 to 2026. Data shows change from $604.78 Million to $480.69 Million (-22.88% CAGR).
Zhejiang Haisen Pharmaceutical Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Haisen Pharmaceutical Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.20x
Zhejiang Haisen Pharmaceutical Co. Ltd. A's market cap is 1.20 times its annual revenue
0.84x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
4.62x
Zhejiang Haisen Pharmaceutical Co. Ltd. A's market cap is 4.62 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $604.78 Million | $397.45 Million | $104.67 Million | 1.52x | 5.78x |
| 2024 | $565.61 Million | $471.51 Million | $122.56 Million | 1.20x | 4.62x |
Competitor Companies of 001367 by Market Capitalization
Companies near Zhejiang Haisen Pharmaceutical Co. Ltd. A in the global market cap rankings as of March 18, 2026.
Key companies related to Zhejiang Haisen Pharmaceutical Co. Ltd. A by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Zhejiang Haisen Pharmaceutical Co. Ltd. A Historical Marketcap From 2023 to 2026
Between 2023 and today, Zhejiang Haisen Pharmaceutical Co. Ltd. A's market cap moved from $604.78 Million to $ 480.69 Million, with a yearly change of -22.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥480.69 Million | +5.47% |
| 2025 | CN¥455.77 Million | -19.42% |
| 2024 | CN¥565.61 Million | -6.48% |
| 2023 | CN¥604.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Zhejiang Haisen Pharmaceutical Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $480.69 Million USD |
| MoneyControl | $480.69 Million USD |
| MarketWatch | $480.69 Million USD |
| marketcap.company | $480.69 Million USD |
| Reuters | $480.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.